Exenatide Injection

DRUG5 trials

Sponsors

Intarcia Therapeutics, Sun Yat-sen University, University of Tartu, Theracos, Neuroscience Trials Australia

Conditions

Acute Ischemic StrokeDiabetes Mellitus, Type 2HealthyNewly DiagnosedType 2 DiabetesType2 Diabetes Mellitus

Phase 1

Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection

CompletedNCT03167411

TheracosType2 Diabetes Mellitus

Start: 2017-05-24End: 2017-06-29Updated: 2021-05-28

Phase 2

Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus

CompletedNCT00943917

Intarcia TherapeuticsType 2 Diabetes

Start: 2009-08-31End: 2011-02-28Updated: 2015-04-13

Trial of EXenatide in Acute Ischaemic Stroke

Neuroscience Trials AustraliaAcute Ischemic Stroke

Start: 2017-11-23End: 2021-12-31Updated: 2021-09-14

Phase 4

Effect of Exenatide on Cortisol Secretion

CompletedNCT03160261

University of TartuHealthy

Start: 2017-09-07End: 2017-12-28Updated: 2018-05-03

Unknown Phase

Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

CompletedNCT01147627

Sun Yat-sen UniversityDiabetes Mellitus, Type 2, Newly Diagnosed

Start: 2010-08-31End: 2012-12-31Updated: 2013-08-21

Related Papers

Management of Poststroke Hyperglycemia: Results of the TEXAIS Randomized Clinical Trial

Stroke2023-11-2727 citations

GLP-1 Receptor Agonists Induce Growth Hormone Secretion in Healthy Volunteers

Diabetes Therapy2023-02-1721 citations